Navigation Links
Illuminated PHOROPTOR Refracting Instrument - Minus Cylinder White

ProductsIlluminated PHOROPTOR Refracting Instrument - Minus Cylinder White
Company Reichert, Inc.
Item Illuminated PHOROPTOR Refracting Instrument - Minus Cylinder White
Features 
  • Minus Cylinder White
  • Illuminated sphere, cylinder, and axis dials
  • Energy efficient, maintenance-free, LED illumination
  • Legendary Reichert feel and quality
  • Lifetime Warranty
Description The Illuminated Phoroptor features lighted dials to make it easier and more efficient to perform refractions in the darkened setting of the exam room. Put away your pen light and leave the lights off throughout the entire process. The Illuminated Phoroptor features lighted sphere, cylinder power and cylinder axis scales that are easier than ever to see. The Illuminated Phoroptor utilizes cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darkened refracting environment. The patent pending LED design results in maintenance-free illumination without the need to ever change a bulb.
Info Reichert, Inc.
Customer Service: 716-686-4500
Web site: http://www.reichert.com/

Related medicine products :

1. Illuminated Phoroptor
2. Non-Illuminated Trial Lens Set
3. Illuminated Trial Lens Set
4. Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted
5. Khosla Non-Illuminated Trial Lens Set, With Lenses Mounted
6. Illuminated Stand Magnifier
7. Illuminated PHOROPTOR Refracting Instrument
8. Illuminated PHOROPTOR Refracting Instrument - Plus Cylinder Black
9. Illuminated PHOROPTOR Refracting Instrument - Plus Cylinder White
10. Burton 7500-I Illuminated Refractor
11. Illuminated Laser Probe, Wide Field, Fully Reusable, Autoclavable
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture.
...provide superior tissue excision with precision-ma...pers offer an aggressive tooth pattern to capture ...nique stress pin buffering system to minimize tip ...ffering system applies increasing tension to the i...
Athroscopic leg holder system.
...er-pumps, the REVOLUTION provides continuous flow,...ermore the dual pump system gives the surgeon tota...ate. , ,The REVOLUTION system includes foot pedal ...y to increase flow while maintaining joint pressur...
Medicine Products:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...a given after 5 years of Tamoxifen therapy is foun...cancer recurrence. Breast cancer is the second lea...tly occurs in post menopausal women and various ri...ence of breast cancer. Treatment of breast cancer...
...abies were born prematurely in a single year, acco... them at increased risk for death and disability. ...ts -- were born prematurely (less than 37 weeks ge...rcent (or about 480,000 babies) in 2002 – and an i...
...that baby in the womb of pregnant women can be dam...cleaning products. It was also found that these ch...he umbilical cord. The study was conducted in 27 n...e tested for 8 groups of chemicals. All the tested...
...he 'Southampton Remedi-Hand' has been developed by...hand better than any currently available. // The h...of complex movements and actions. The artificially... of motors and gears and is designed in such a way...
Other Medicine News:Health News:Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence 2Health News:Toxic chemicals found in domestic products poisoning newborn babies 2Health News:New ultralight hand with better functionality and flexibility developed 2
(Date:10/7/2008)...T, Mich., Oct. 7 /- McLaren Health Ca...ing some of the world,s leading medical,minds to s...breast and,gastrointestinal cancer treatments. The...I, was organized by McLaren,s Sukamal Saha, M.D., ... sentinel node mapping for,colorectal cancer has g...
(Date:10/7/2008)...OUVER, Oct. 7 / Burcon Nutr...hat its Puratein(R) and,Supertein(TM) canola prote...) for their intended use in a variety of food and ...-affirmed GRAS through an,independent evaluation b...od safety, toxicology, nutritional sciences, food ...
(Date:10/7/2008)... COLLINS, Colo., Oct. 7 /- A study pu... embryonic stem cell self-renewal,reported that I...ecombinant,human serum albumin) was an effective r...ure., The article entitled, "The ground state of ...researchers used Cellastim as a recombinant,albumi...
(Date:10/7/2008)...ral abstracts highlighting CIMZIA,s long-term bene...se patients presented at American College,of Gastr...re-FirstCall/ -- Data from two studies,presented t...nterology,(ACG) Annual Meeting demonstrate that CI...anti-TNF alpha (Tumor Necrosis Factor alpha) - pro...
Breaking Medicine Technology:News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9School vending machines dole out excess calories fat 27023 1School vending machines dole out excess calories fat 27023 2Childrens asthma affected by parental expectations 27018 1Childrens asthma affected by parental expectations 27018 2Mental barriers hamper obese womens efforts to get exercise 27017 1Mental barriers hamper obese womens efforts to get exercise 27017 2Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 1Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 2Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 3Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 4Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 5Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 6
...rld,s First Commercial Vaccine,for Travellers, Dia...tes Phase I Clinical Trials , ,Trial confirms good..., Denmark, March 28, 2007 -ACE BioSciences A/S, th...ce the successful,completion of Phase I clinical t...irst commercial vaccine for Travellers,Diarrhoea ...
...ey Lung Compartments, REINACH and BASEL, Switzerla...a Ltd. today announced promising,results of "first...Human Microdose studies included a total of 19 hea...is the first ever using Microdosing,for the determ...s.,The results showed that AR-709 achieves high co...
Other Medicine Technology:Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 2Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 3Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5